Page 182 - An Evidence Review of Active Surveillance in Men With Localized Prostate Cancer

Appendix Table C1.1. Descriptive characteristics of the epidemiologic studies considered relevant to KQ1 (continued)
Author Database Start End year Sample size Eligibility criteria
Year year
uid
72
Mettlin NCDB 1985 1990 85,813 NR
1994
8062197
73
Mettlin NCDB 1985 1993 349,154 Convenience sample of cancer patients in hospitals that voluntarily
1996 participated in the database.
8640686
74
Mettlin NCDB 1986 1992 108,717 All submitted data to NCDB in 1986-1987 and in 1992. The available data
1995 [number of patients represented ~30% and 77% of all prostate cancers diagnosed in the US in
8625214 included in analyses 1986/1987 and 1992, respectively.
of stage by time
period; the analytic
sample size varied
between analyses]
75
Mettlin NCDB 1992 1995 176,316 NR
1998
9781963
91
Mettlin NCDB 1992 1996 435,264 Prostate carcinoma (as reported from participating hospitals).
1999
10547563
76
Danley LAC/USC 1976 1988 29,992 Invasive prostate cancer patients, aged ≥45 yr. Excluded men younger than
1995 CSP 45 yr of age.
8580296
77
Hamilton POCS, NCI 1998 2002 2101 The 1998 POCS included primary histologically confirmed prostate cancer
2011 [962 in 1998 and patients diagnosed between Jan 1st, 1998 and Dec 31st, 1998. Patients with
20735387 1139 in 2002; the a history of previous cancer (except non-melanoma skin cancer) and those
weighted sample aged <21 yr were excluded. A stratified random sample of all prostate cancer
size was 15,547 for cases diagnosed in 10 regional population based cancer registries were
1998 and 31,367 in selected, according to patients’ race/ethnicity and age at diagnosis. For the
2002] 2002 POCS, similar procedures were followed as in 1998 with the inclusion of
additional registries.
92
White Texas 1995 2002 87,444 Incident invasive prostate cancer cases in men ≥25 yrs (last date of follow-
2011 Cancer [87,449 in abstract] up was December 31, 2003)
21351084 Registry
Studies are arranged by database, then chronologically by the first year of enrollment, then by year of publication.
ACTUR = Automated Central Tumor Registry; ADT = androgen deprivation therapy; BT = brachytherapy; EBRT = external beam radiation therapy; HMO = health maintenance
organization; mo = months; NCHS = National Center for health Statistics; NR = not reported; POCS = Patterns of Care; PSA = prostate-specific antigen; QoL = quality of life;
RT = radiation therapy; RP = radical prostatectomy; TNCS = Third National Cancer Survey; VA = Veteran’s Administration; WW = watchful waiting; yr = year.

C-9